RHINALAR NASAL MIST 25 MCG
FLUNISOLIDE : 25 MCG · DIN 02162687 · IVAX LABORATORIES INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is RHINALAR NASAL MIST?
RHINALAR NASAL MIST 25 MCG contains FLUNISOLIDE : 25 MCG. It is listed in the Health Canada Drug Product Database under DIN 02162687, held by IVAX LABORATORIES INCORPORATED, supplied as SOLUTION ; SPRAY for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Oct-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02162687 |
|---|---|
| Brand name | RHINALAR NASAL MIST |
| Generic / active ingredient | FLUNISOLIDE : 25 MCG |
| Manufacturer | IVAX LABORATORIES INCORPORATED |
| Strength | 25 MCG |
| Dosage form | SOLUTION ; SPRAY |
| Route of administration | NASAL |
| Schedule | Prescription |
| ATC code | R01AD04 FLUNISOLIDE |
| AHFS class | 52:08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Oct-2015 |
| Original market date | 1996-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R01AD04 FLUNISOLIDE. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-FLUNISOLIDE NASAL SPRAY | 0.25 MG | METERED-DOSE PUMP | APOTEX INC | CANCELLED POST MARKET | DIN 02239288 |
| NOVO-FLUNISOLIDE | 25 MCG | SPRAY | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02230306 |
| PMS-FLUNISOLIDE | 0.025 % | SPRAY | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 01927167 |
| RATIO-FLUNISOLIDE | 25 MCG | SPRAY | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 00878790 |
| RHINALAR | .025 % | SPRAY | SYNTEX INC. | CANCELLED POST MARKET | DIN 00421456 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.